Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India: Our Bureau, Mumbai Saturday, July 4, 2026, 11:45 Hrs [IST] Zydus Lifesci ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

Men often learn to live with discomfort. A little back pain, getting up twice at night to use the washroom, or a weak urine ...

Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

Prostate cancer is the most common cancer among men after skin cancer, according to the American Cancer Society.

Prostate health awareness helps men identify early signs, understand risks, and navigate PSA tests and screening with trusted ...

Bladder cancer remains one of the most frequently diagnosed urologic malignancies worldwide, imposing a heavy and persistent ...

Nearly four in 10 women were initially told they had a UTI before later being diagnosed with bladder cancer. The post Bladder ...

June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...